Nectar Lifesciences Limited (NECLIFE.NS)
INR 21.88
(-3.48%)
INR 21.88
(-3.48%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.89 Billion INR | 1885.82% |
| 2022 | -51.73 Million INR | -105.09% |
| 2021 | 1.01 Billion INR | 103.23% |
| 2020 | 499.91 Million INR | -68.62% |
| 2019 | 1.59 Billion INR | -20.82% |
| 2018 | 2.01 Billion INR | 16.77% |
| 2017 | 1.72 Billion INR | 6.08% |
| 2016 | 1.62 Billion INR | -17.41% |
| 2015 | 1.96 Billion INR | 3.31% |
| 2014 | 1.9 Billion INR | -6.93% |
| 2013 | 2.04 Billion INR | -4.49% |
| 2012 | 2.14 Billion INR | 22.02% |
| 2011 | 1.75 Billion INR | -9.32% |
| 2010 | 1.93 Billion INR | 17.52% |
| 2009 | 1.64 Billion INR | 51.36% |
| 2008 | 1.08 Billion INR | -16.82% |
| 2007 | 1.3 Billion INR | 74.52% |
| 2006 | 749.65 Million INR | 7.42% |
| 2005 | 697.9 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 243.43 Million INR | -27.99% |
| 2023 Q1 | 202.07 Million INR | -4.38% |
| 2023 FY | 923.8 Million INR | 1885.82% |
| 2023 Q4 | 338.03 Million INR | 26.05% |
| 2023 Q3 | 268.16 Million INR | 21.01% |
| 2023 Q2 | 221.6 Million INR | 9.66% |
| 2022 Q3 | -979 Thousand INR | 99.15% |
| 2022 Q1 | 271.13 Million INR | -22.3% |
| 2022 FY | -51.73 Million INR | -105.09% |
| 2022 Q2 | -114.79 Million INR | -142.34% |
| 2022 Q4 | 211.32 Million INR | 21686.01% |
| 2021 FY | 1.01 Billion INR | 103.23% |
| 2021 Q4 | 348.94 Million INR | 7.99% |
| 2021 Q3 | 323.11 Million INR | 142.88% |
| 2021 Q2 | 133.03 Million INR | -36.92% |
| 2021 Q1 | 210.89 Million INR | -20.32% |
| 2020 FY | 499.91 Million INR | -68.62% |
| 2020 Q2 | 163.78 Million INR | 920.52% |
| 2020 Q1 | 16.04 Million INR | -95.87% |
| 2020 Q4 | 264.66 Million INR | 49.89% |
| 2020 Q3 | 176.56 Million INR | 7.8% |
| 2019 Q3 | 407.63 Million INR | 19.61% |
| 2019 Q4 | 388.96 Million INR | -4.58% |
| 2019 Q2 | 340.81 Million INR | -25.24% |
| 2019 FY | 1.59 Billion INR | -20.82% |
| 2019 Q1 | 455.89 Million INR | -24.21% |
| 2018 Q2 | 488.32 Million INR | 11.33% |
| 2018 Q1 | 438.63 Million INR | 0.0% |
| 2018 FY | 2.01 Billion INR | 16.77% |
| 2018 Q4 | 601.48 Million INR | 24.33% |
| 2018 Q3 | 483.79 Million INR | -0.93% |
| 2017 FY | 1.72 Billion INR | 6.08% |
| 2016 FY | 1.62 Billion INR | -17.41% |
| 2015 Q3 | - INR | 0.0% |
| 2015 FY | 1.96 Billion INR | 3.31% |
| 2015 Q4 | - INR | 0.0% |
| 2014 FY | 1.9 Billion INR | -6.93% |
| 2014 Q4 | - INR | 0.0% |
| 2014 Q3 | - INR | 0.0% |
| 2013 FY | 2.04 Billion INR | -4.49% |
| 2012 FY | 2.14 Billion INR | 22.02% |
| 2011 FY | 1.75 Billion INR | -9.32% |
| 2010 FY | 1.93 Billion INR | 17.52% |
| 2009 FY | 1.64 Billion INR | 51.36% |
| 2008 FY | 1.08 Billion INR | -16.82% |
| 2007 FY | 1.3 Billion INR | 74.52% |
| 2006 FY | 749.65 Million INR | 7.42% |
| 2005 FY | 697.9 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 32.433% |
| Hester Biosciences Limited | 364.77 Million INR | -966.587% |
| Aarti Drugs Limited | 7.14 Billion INR | 45.576% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -24.375% |
| Albert David Limited | 1.33 Billion INR | -191.549% |
| Alembic Limited | 767.77 Million INR | -406.739% |
| Alkem Laboratories Limited | 19.46 Billion INR | 80.009% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -1537.033% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -18735.157% |
| Brooks Laboratories Limited | -72.25 Million INR | 5484.751% |
| Eris Lifesciences Limited | 5.18 Billion INR | 24.917% |
| FDC Limited | 3.03 Billion INR | -28.244% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 56.671% |
| Gufic Biosciences Limited | 2.89 Billion INR | -34.446% |
| Hikal Limited | 1.49 Billion INR | -160.379% |
| Ind-Swift Limited | 1.22 Billion INR | -217.349% |
| Innova Captab Limited | 2.53 Billion INR | -53.571% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 21.278% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -1717.693% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 25.022% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -104.088% |
| Lupin Limited | 27.75 Billion INR | 85.984% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -14069.24% |
| Medico Remedies Limited | 277.11 Million INR | -1303.947% |
| Morepen Laboratories Limited | 4.17 Billion INR | 6.786% |
| Orchid Pharma Limited | 2.36 Billion INR | -64.78% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -39.648% |
| RPG Life Sciences Limited | 2.29 Billion INR | -69.724% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -1770.026% |
| Sigachi Industries Limited | 1.47 Billion INR | -163.966% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 200.978% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 15.562% |
| Themis Medicare Limited | 1.3 Billion INR | -198.563% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -61714.268% |
| Wanbury Limited | 1.7 Billion INR | -127.892% |
| Windlas Biotech Limited | 1.29 Billion INR | -199.532% |
| ZIM Laboratories Limited | 1.09 Billion INR | -254.298% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -93.655% |
| Ipca Laboratories Limited | 29.59 Billion INR | 86.855% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 96.27% |
| Venus Remedies Limited | 534.65 Million INR | -627.688% |
| Sakar Healthcare Limited | 495.5 Million INR | -685.175% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 96.277% |
| Divi's Laboratories Limited | 18.31 Billion INR | 78.752% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 13.038% |
| Mankind Pharma Limited | 40.86 Billion INR | 90.48% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | 1.469% |
| Neuland Laboratories Limited | 5.31 Billion INR | 26.842% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 48.412% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 40.167% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 91.429% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -526.477% |
| Wockhardt Limited | 140 Million INR | -2678.993% |
| Bal Pharma Limited | 214.56 Million INR | -1713.212% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 94.256% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -216.051% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -605.342% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 46.153% |
| Shilpa Medicare Limited | 3.76 Billion INR | -3.43% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 80.228% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -137336.564% |
| Granules India Limited | 6.52 Billion INR | 40.404% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1460.912% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 84.644% |
| NATCO Pharma Limited | 25.96 Billion INR | 85.014% |
| Suven Life Sciences Limited | -1.22 Billion INR | 417.386% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 25.55% |
| Indoco Remedies Limited | 1.52 Billion INR | -155.221% |
| Alpa Laboratories Limited | 61.51 Million INR | -6224.62% |
| Lasa Supergenerics Limited | -458 Million INR | 949.465% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 194.546% |